GB8819836D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB8819836D0
GB8819836D0 GB888819836A GB8819836A GB8819836D0 GB 8819836 D0 GB8819836 D0 GB 8819836D0 GB 888819836 A GB888819836 A GB 888819836A GB 8819836 A GB8819836 A GB 8819836A GB 8819836 D0 GB8819836 D0 GB 8819836D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB888819836A
Other versions
GB2222165B (en
GB2222165A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute for Animal Health
Original Assignee
Institute for Animal Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute for Animal Health filed Critical Institute for Animal Health
Priority to GB8819836A priority Critical patent/GB2222165B/en
Publication of GB8819836D0 publication Critical patent/GB8819836D0/en
Priority to AU41909/89A priority patent/AU621934B2/en
Priority to EP89909820A priority patent/EP0432196A1/en
Priority to PCT/GB1989/000965 priority patent/WO1990002190A1/en
Priority to ZA896372A priority patent/ZA896372B/en
Publication of GB2222165A publication Critical patent/GB2222165A/en
Priority to OA59949A priority patent/OA09636A/en
Application granted granted Critical
Publication of GB2222165B publication Critical patent/GB2222165B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB8819836A 1988-08-20 1988-08-20 Recombinant capripoxvirus Expired - Fee Related GB2222165B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB8819836A GB2222165B (en) 1988-08-20 1988-08-20 Recombinant capripoxvirus
AU41909/89A AU621934B2 (en) 1988-08-20 1989-08-18 Insertion of heterologous gene from a pathogen to produce a recombinant capripoxvirus
EP89909820A EP0432196A1 (en) 1988-08-20 1989-08-18 Vaccine
PCT/GB1989/000965 WO1990002190A1 (en) 1988-08-20 1989-08-18 Vaccine
ZA896372A ZA896372B (en) 1988-08-20 1989-08-21 Vaccine
OA59949A OA09636A (en) 1988-08-20 1991-02-18 Vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8819836A GB2222165B (en) 1988-08-20 1988-08-20 Recombinant capripoxvirus

Publications (3)

Publication Number Publication Date
GB8819836D0 true GB8819836D0 (en) 1988-09-21
GB2222165A GB2222165A (en) 1990-02-28
GB2222165B GB2222165B (en) 1992-06-17

Family

ID=10642474

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8819836A Expired - Fee Related GB2222165B (en) 1988-08-20 1988-08-20 Recombinant capripoxvirus

Country Status (6)

Country Link
EP (1) EP0432196A1 (en)
AU (1) AU621934B2 (en)
GB (1) GB2222165B (en)
OA (1) OA09636A (en)
WO (1) WO1990002190A1 (en)
ZA (1) ZA896372B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2602790B1 (en) * 1986-08-13 1990-06-01 Transgene Sa EXPRESSION OF A SPECIFIC TUMOR ANTIGEN BY A RECOMBINANT VECTOR VIRUS AND USE THEREOF FOR THE PREVENTIVE OR CURATIVE TREATMENT OF THE CORRESPONDING TUMOR
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0261940A3 (en) * 1986-09-23 1989-07-05 Applied Biotechnology, Inc. Pseudorabies vaccines and dna vectors for recombination with pox viruses

Also Published As

Publication number Publication date
GB2222165B (en) 1992-06-17
WO1990002190A1 (en) 1990-03-08
AU4190989A (en) 1990-03-23
EP0432196A1 (en) 1991-06-19
ZA896372B (en) 1990-07-25
GB2222165A (en) 1990-02-28
OA09636A (en) 1993-04-30
AU621934B2 (en) 1992-03-26

Similar Documents

Publication Publication Date Title
GB8907914D0 (en) Vaccine preparation
EP0391997A4 (en) Vaccine
EP0256878A3 (en) Vaccines
ZA88149B (en) Anti-reproductive vaccines
GB8921470D0 (en) Vaccines
GB8702691D0 (en) Vaccines
KR970007376B1 (en) Coccidiosis vaccine
ZW22487A1 (en) Vaccine
ZA874847B (en) Oncornavirus vaccines
GB8815560D0 (en) Improved last
GB8704647D0 (en) Vaccine
OA09636A (en) Vaccine
GB8615068D0 (en) Vaccines
GB8912496D0 (en) Vaccines
EP0453452A4 (en) Vaccine
IE882054L (en) Vaccine
GB8805603D0 (en) Vaccine
IE880831L (en) Vaccines
GB8810807D0 (en) Vaccines
GB8804688D0 (en) Vaccines
GB8605646D0 (en) Vaccines
GB8922651D0 (en) Vaccine
GB8712685D0 (en) Vaccine
IE892784L (en) Vaccines
GB8914532D0 (en) Vaccines

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930820